CETP inhibition: Confusion, conflicting results but promising developments
Prof. Philip Barter, Sydney, with a brief update on where we are now with the development of new CETP inhibitors
President, International Atherosclerosis Society
Centre for Vascular Research, University of New South Wales
Sydney, Australia

Share this page with your colleagues and friends: